Sarepta Therapeutics Inc (SRPT)
104.54
-4.57
(-4.19%)
USD |
NASDAQ |
Nov 15, 16:00
105.94
+1.40
(+1.34%)
After-Hours: 07:23
Sarepta Therapeutics Price: 104.54 for Nov. 15, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 15, 2024 | 108.54 | 108.70 | 102.57 | 104.54 | 1.570M |
| Nov 14, 2024 | 112.58 | 112.58 | 109.01 | 109.11 | 1.453M |
| Nov 13, 2024 | 113.63 | 116.30 | 111.53 | 112.48 | 961893.0 |
| Nov 12, 2024 | 118.00 | 118.72 | 114.12 | 114.32 | 1.110M |
| Nov 11, 2024 | 121.88 | 122.63 | 117.53 | 117.84 | 1.144M |
| Nov 08, 2024 | 120.50 | 121.96 | 116.32 | 121.61 | 1.485M |
| Nov 07, 2024 | 132.40 | 133.00 | 117.52 | 120.42 | 2.394M |
| Nov 06, 2024 | 126.50 | 128.32 | 122.45 | 127.97 | 1.454M |
| Nov 05, 2024 | 123.00 | 125.25 | 121.18 | 125.01 | 825790.0 |
| Nov 04, 2024 | 123.30 | 124.03 | 121.01 | 123.07 | 973205.0 |
| Nov 01, 2024 | 125.91 | 126.51 | 122.68 | 123.29 | 1.141M |
| Oct 31, 2024 | 127.32 | 128.19 | 125.92 | 126.00 | 652347.0 |
| Oct 30, 2024 | 129.32 | 130.86 | 127.40 | 127.78 | 658068.0 |
| Oct 29, 2024 | 130.07 | 131.17 | 129.26 | 130.21 | 431757.0 |
| Oct 28, 2024 | 131.37 | 132.80 | 129.26 | 130.26 | 515932.0 |
| Oct 25, 2024 | 132.10 | 133.36 | 130.93 | 131.14 | 849647.0 |
| Oct 24, 2024 | 129.90 | 132.88 | 129.53 | 132.02 | 737633.0 |
| Oct 23, 2024 | 131.00 | 131.00 | 126.78 | 129.88 | 737382.0 |
| Oct 22, 2024 | 126.26 | 128.54 | 126.20 | 128.42 | 514391.0 |
| Oct 21, 2024 | 127.73 | 129.24 | 126.58 | 127.31 | 859182.0 |
| Oct 18, 2024 | 124.98 | 130.04 | 124.26 | 127.08 | 1.028M |
| Oct 17, 2024 | 125.60 | 127.18 | 124.21 | 124.25 | 896123.0 |
| Oct 16, 2024 | 123.66 | 126.34 | 123.66 | 125.92 | 612987.0 |
| Oct 15, 2024 | 124.37 | 124.98 | 123.22 | 123.73 | 656161.0 |
| Oct 14, 2024 | 124.42 | 124.94 | 122.74 | 124.37 | 414738.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
62.69
Minimum
Jun 16 2022
178.74
Maximum
Dec 22 2020
111.29
Average
114.78
Median
Price Benchmarks
| Catalyst Pharmaceuticals Inc | 20.60 |
| Madrigal Pharmaceuticals Inc | 288.58 |
| Vertex Pharmaceuticals Inc | 465.70 |
| Viking Therapeutics Inc | 49.58 |
| Regenxbio Inc | 9.63 |
Price Related Metrics
| PE Ratio | 67.88 |
| PS Ratio | 6.412 |
| Price to Book Value | 8.178 |
| Earnings Yield | 1.47% |
| Market Cap | 9.986B |
| Operating PE Ratio | 129.82 |
| Normalized PE Ratio | 64.08 |